gefitinib has been researched along with niclosamide in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (niclosamide) | Trials (niclosamide) | Recent Studies (post-2010) (niclosamide) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 979 | 19 | 465 |
| Protein | Taxonomy | gefitinib (IC50) | niclosamide (IC50) |
|---|---|---|---|
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | Plasmodium berghei | 13.7 | |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 10 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.28 | |
| Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | 10 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 0.23 | |
| Anoctamin-1 | Homo sapiens (human) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaofeng, P; Hexiao, T; Jinping, Z; Laiyi, W; Li, Z; Ming, X; Xuefeng, Z; Yanhong, W; Yuquan, B | 1 |
1 other study(ies) available for gefitinib and niclosamide
| Article | Year |
|---|---|
Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Progression; ErbB Receptors; Female; Gefitinib; Glycoproteins; Humans; Lung Neoplasms; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Niclosamide; Prognosis; Proto-Oncogene Proteins c-akt; Receptors, Interleukin-6 | 2019 |